Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.55
-0.23 (-2.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 38.79 | 47.54 | 21.25 | 1.54 | - | 0.17 | Upgrade
|
| Revenue Growth (YoY) | -21.39% | 123.69% | 1284.50% | - | - | - | Upgrade
|
| Cost of Revenue | 2.67 | 3.18 | 1.26 | 0.09 | - | - | Upgrade
|
| Gross Profit | 36.12 | 44.35 | 19.99 | 1.45 | - | 0.17 | Upgrade
|
| Selling, General & Admin | 40.5 | 41.48 | 32.71 | 20.51 | 12.24 | 12.95 | Upgrade
|
| Research & Development | 0.28 | 0.31 | 0.06 | 3.53 | 4.98 | 5.11 | Upgrade
|
| Operating Expenses | 40.78 | 41.79 | 32.76 | 24.04 | 17.22 | 18.06 | Upgrade
|
| Operating Income | -4.66 | 2.57 | -12.77 | -22.59 | -17.22 | -17.89 | Upgrade
|
| Interest Expense | -2.8 | -4.16 | -3.68 | -1.13 | -0.14 | -0.41 | Upgrade
|
| Interest & Investment Income | 0.96 | 1.68 | 0.44 | 0.2 | 0.05 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.08 | 0.01 | -0.01 | -0.01 | - | Upgrade
|
| EBT Excluding Unusual Items | -6.51 | 0.01 | -16.01 | -23.53 | -17.32 | -18.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.07 | -0.08 | -0.04 | -0.18 | -0.03 | 0.1 | Upgrade
|
| Pretax Income | -6.57 | -0.07 | -16.05 | -23.71 | -17.35 | -18.11 | Upgrade
|
| Income Tax Expense | 0.37 | 0.37 | - | - | - | - | Upgrade
|
| Net Income | -6.94 | -0.44 | -16.05 | -23.71 | -17.35 | -18.11 | Upgrade
|
| Net Income to Common | -6.94 | -0.44 | -16.05 | -23.71 | -17.35 | -18.11 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 27 | 27 | 26 | 26 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 27 | 27 | 26 | 26 | 24 | Upgrade
|
| Shares Change (YoY) | 1.25% | 2.71% | 1.14% | 1.03% | 9.71% | 19.14% | Upgrade
|
| EPS (Basic) | -0.25 | -0.02 | -0.60 | -0.90 | -0.67 | -0.76 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.02 | -0.60 | -0.90 | -0.67 | -0.76 | Upgrade
|
| Gross Margin | 93.12% | 93.30% | 94.08% | 94.40% | - | 100.00% | Upgrade
|
| Operating Margin | -12.02% | 5.40% | -60.09% | -1471.60% | - | -10520.59% | Upgrade
|
| Profit Margin | -17.89% | -0.92% | -75.50% | -1544.89% | - | -10652.35% | Upgrade
|
| EBITDA | -4.33 | 3.6 | - | - | - | - | Upgrade
|
| EBITDA Margin | -11.15% | 7.57% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.34 | 1.03 | - | - | - | - | Upgrade
|
| EBIT | -4.66 | 2.57 | -12.77 | -22.59 | -17.22 | -17.89 | Upgrade
|
| EBIT Margin | -12.02% | 5.40% | -60.09% | - | - | - | Upgrade
|
| Revenue as Reported | 38.79 | 47.54 | 21.25 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.